In his state-of-the-art presentation, Professor Henry Ginsberg discusses the role of TG-rich lipoproteins (TGRLs) and their remnants in atherosclerotic cardiovascular disease, with a focus on how and why remnants accumulate in some individuals and how levels of remnant particles and their cholesterol can be assessed.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
